Ryan C. Pouliot

Jul 1, 2024 | mdedge.com | Thomas Hickey |Ryan C. Pouliot

Publish date: July 1, 2024 Dear colleagues,Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are revolutionizing the field of obesity management and are now common medication in patients presenting for endoscopy. With their effect on gastric emptying, the American Society of Anesthesiologists has recommended cessation of such agents prior to endoscopy.